Plant investigation: as the device was not returned to the manufacturer, a physical evaluation could not be performed.However, a photograph of the alleged malfunction was provided by the customer.In the photograph, it can be observed that the ¿y¿ injection site of the priming line is leaking.The reported issue is confirmed.The priming line used in the arterial line is a component that is manufactured by an external supplier; therefore, this kind of failure mode could only be caused by the external supplier.A notification was made to the external supplier about the alleged incident related to the injection site.A batch records review was conducted by the manufacturer for the reported lot.There were no non-conformances or abnormalities identified during the manufacturing process which could be associated with the reported event.The entire lot has been sold and distributed.In addition, a device history review was performed and confirmed that the results of the in-progress and final quality control (qc) testing met all requirements.The lot met all specifications for release.
|